batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Another bump in Moderna’s neoantigen road 13 October 2025 Competition crowds out Torl's conjugate efforts 10 October 2025 Bristol is next into in vivo Car-T 10 October 2025 Questions mount for Eisai's Elahere wannabe 10 October 2025 Regeneron scores in adjuvant skin cancer 9 October 2025 PD-L1 degraders emerge 9 October 2025 ESMO 2025 preview – Junshi goes pivotal in PI3Kα 8 October 2025 Girentuximab nears the finish line, maybe 6 October 2025 Load More